Millennium Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.85M | Sell |
1,207,802
-112,293
| -9% | -$730K | ﹤0.01% | 1792 |
|
2025
Q1 | $10.5M | Buy |
1,320,095
+1,127,995
| +587% | +$8.95M | 0.01% | 1483 |
|
2024
Q4 | $2.43M | Buy |
192,100
+85,606
| +80% | +$1.08M | ﹤0.01% | 2410 |
|
2024
Q3 | $1.48M | Sell |
106,494
-61,271
| -37% | -$854K | ﹤0.01% | 2721 |
|
2024
Q2 | $2.31M | Buy |
167,765
+138,757
| +478% | +$1.91M | ﹤0.01% | 2403 |
|
2024
Q1 | $479K | Buy |
+29,008
| New | +$479K | ﹤0.01% | 3323 |
|
2023
Q4 | – | Sell |
-35,786
| Closed | -$439K | – | 4182 |
|
2023
Q3 | $439K | Sell |
35,786
-452,338
| -93% | -$5.55M | ﹤0.01% | 3318 |
|
2023
Q2 | $5.83M | Buy |
488,124
+268,454
| +122% | +$3.21M | ﹤0.01% | 1831 |
|
2023
Q1 | $2.94M | Buy |
+219,670
| New | +$2.94M | ﹤0.01% | 2268 |
|
2022
Q3 | – | Sell |
-17,555
| Closed | -$314K | – | 5212 |
|
2022
Q2 | $314K | Sell |
17,555
-157,168
| -90% | -$2.81M | ﹤0.01% | 4198 |
|
2022
Q1 | $1.73M | Buy |
+174,723
| New | +$1.73M | ﹤0.01% | 3174 |
|
2021
Q4 | – | Sell |
-177,945
| Closed | -$4.22M | – | 5263 |
|
2021
Q3 | $4.22M | Buy |
+177,945
| New | +$4.22M | ﹤0.01% | 2347 |
|